Liver Cancer Management

Introduction to Liver Cancer Treatment

• The American Association for the Study of Liver Diseases recommends surgical resection for solitary tumors with preserved liver function, liver transplantation for patients with decompensated cirrhosis and HCC within accepted criteria, and thermal ablation for selected patients with solitary <2 cm HCC in compensated cirrhosis 1
• The American Gastroenterological Association recommends atezolizumab plus bevacizumab as first-line systemic therapy for patients with preserved liver function, and sorafenib or lenvatinib for patients who are not candidates for atezolizumab plus bevacizumab 2

Systemic Therapy for Advanced HCC

• The American Gastroenterological Association recommends second-line options including cabozantinib, pembrolizumab, ramucirumab, or regorafenib for patients with advanced HCC 2

Pain Management in Liver Cancer

• For patients with liver cancer, the American Association for the Study of Liver Diseases recommends acetaminophen at reduced doses (2000-3000 mg/day) as the safest first-line option for mild pain in cirrhotic patients, with regular liver function monitoring 3, 4, 5, 6, 7
• Tramadol can be used with significant dose reduction, with a maximum of 50 mg every 12 hours in cirrhotic patients, and avoiding use with serotonergic medications due to seizure risk, as suggested by the American Association for the Study of Liver Diseases 3, 8
• The American Association for the Study of Liver Diseases advises against the use of codeine due to the risk of metabolite accumulation and respiratory depression 3
• Fentanyl is the preferred opioid for severe pain in cirrhotic patients due to its minimal hepatic metabolism, available in multiple formulations (patch, sublingual, IV) 3, 4
• Morphine can be used as a second-line option with significant dose reduction (50%) and extended dosing interval (1.5-2 fold), with bioavailability being four times higher in patients with hepatocellular carcinoma compared to healthy individuals 3
• The American Association for the Study of Liver Diseases recommends avoiding hydromorphone and methadone due to metabolite accumulation and unpredictable half-life 3
• Oxycodone can be used at lower initial doses with careful monitoring, and has decreased intrinsic hepatic clearance in cirrhosis, according to the Clinical and Molecular Hepatology guidelines 3
• Methadone is contraindicated in severe liver disease due to unpredictable half-life and potential for accumulation and delayed toxicity, but can be used with caution at significantly reduced doses (25-50% of standard dose) and extended dosing intervals 4, 3
• NSAIDs should be strictly avoided in cirrhotic patients due to the risk of nephrotoxicity, renal failure, gastrointestinal bleeding, hepatic decompensation, and increased toxicity, as recommended by the American Association for the Study of Liver Diseases 3, 4, 9
• Gabapentin or pregabalin are preferred for neuropathic pain component due to minimal hepatic metabolism 4, 3, 10
• The American Association for the Study of Liver Diseases recommends vigilant monitoring for signs of hepatic encephalopathy, especially when using opioids, and using the lowest effective dose and extending dosing intervals 3
• Regular assessment of pain using visual analog scales (VAS) or numerical rating scales (NRS), and frequent monitoring of liver function tests with dose adjustments based on hepatic impairment severity are recommended 3, 7, 8
• Mandatory co-prescription of osmotic laxatives with opioids is recommended to prevent constipation and hepatic encephalopathy, as recommended by the American Society of Clinical Oncology 4, 3, 9
• Benzodiazepines should be avoided due to increased risk of falls, injuries, and altered mental status, as recommended by the American Association for the Study of Liver Diseases 4
• Palliative radiotherapy (40 Gy median dose) can be considered for bone metastasis pain, without interfering with liver function, as recommended by the Clinical and Molecular Hepatology guidelines 4
• Gabapentin/pregabalin are preferred over tricyclic antidepressants for neuropathic pain due to non-hepatic metabolism and fewer anticholinergic side effects, as recommended by the European Association for the Study of the Liver 4, 3

Pain Management Strategies by Pain Severity

• For mild pain (NRS 1-4), acetaminophen (reduced dose: 2000-3000 mg/day) and gabapentin/pregabalin for neuropathic component can be used 3
• For moderate pain (NRS 5-7), low-dose transdermal fentanyl (12-25 mcg/hr), gabapentin or pregabalin, and low-dose tramadol (maximum 50 mg/12 hours) with careful monitoring can be considered 3
• For severe pain (NRS 8-10), transdermal or IV fentanyl with careful titration, radiation therapy for bone metastasis pain, and RFA or transarterial embolization for localized pain can be considered, according to the Clinical and Molecular Hepatology guidelines 3
• A multimodal approach combining medications with different mechanisms is recommended for severe pain, as suggested by the American Pain Society and the American Society of Regional Anesthesia and Pain Medicine 3, 9